As we prepare for Q1 2026, sponsors and CROs face a shifting global landscape for clinical trial comparator sourcing that focuses on sustainability, diversity and fair pricing. With our EcoVadis Platinum certification, women-owned business status and full scientific team in place, CSI is well placed to support our partner’s supply chains. 1. Supply-chain volatility is real Clinical supplies are increasingly challenged by geo-political pressures, export controls, and manufactu

Strategy Partnerships for Budget Value As we enter Q4, many clinical operations teams face the familiar challenge of budget utilization....

Earlier this month, the US President signed a landmark executive order aimed at delivering “most favored nation” (MFN) pricing for...

In clinical trials, every element of the supply chain matters. From sourcing high-quality comparator drugs to managing timelines across...

So are we! We’re pleased to share that Jonathan Miller , CSI’s Head of Operations, North America , will be attending Jefferies New York...

CSI’s Strategic Approach to Mitigating Clinical Trial Supply Disruption Recent developments in U.S. trade policy are shaking up supply...

CSI attended the Global Clinical Supplies Group (GCSG) US Conference in San Antonio, Texas, April 27th-30th. The event brought together...

Exciting news! CSI will be exhibiting at GCSG Asia Pacific 2024 this week, on March 12-13 in Seoul! Visit us at Table 7 to learn how our...

CSI will be exhibiting at Booth 21 to meet  Vanessa Dekou PhD, MBA , our Managing Director, along with our Project Manager and Marketing...

A Leading Biotech Client's Challenge A leading biotech client approached CSI to assist in sourcing the comparator drug Lucentis for a...

We’re excited to announce that Stephan Muetze , Director of Project Management, and Yasmine Clemson , Project Management and Marketing...

Which Trends Will Shape Clinical Trial Supplies in 2025? The clinical trial supply industry is rapidly evolving. This change is driven by...

CSI is excited to have our Managing Director Vanessa Dekou featured on the front cover of Life Sciences Magazine!  This recognition is...

Ensuring Efficiency, Compliance and Success Full supply chain management in clinical trial supply encompasses the comprehensive oversight...

CSI's Director of Strategy, Andrea Giochetta is attending BioNJ's BioPartnering Conference at the Liberty Science Centre in New Jersey on...

Ancillaries play a crucial role in ensuring the smooth execution of clinical trials, encompassing a broad range of items, materials and...

Ryvu Therapeutics Announces Entering into Agreement with Clinical Services International (CSI) in the Area of Securing Venetoclax Supply...

The growth in the biosimilar market since 2006 has been significant. Biosimilars have no meaningful clinical differences between the...